Genomic Adaption and Mutational Patterns in a HaCaT Subline Resistant to Alkylating Agents and Ionizing Radiation.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Jan 2021
Historique:
received: 10 12 2020
revised: 15 01 2021
accepted: 20 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 10 4 2021
Statut: epublish

Résumé

Sulfur mustard (SM) is a chemical warfare agent that can damage DNA via alkylation and oxidative stress. Because of its genotoxicity, SM is cancerogenic and the progenitor of many chemotherapeutics. Previously, we developed an SM-resistant cell line via chronic exposure of the popular keratinocyte cell line HaCaT to increasing doses of SM over a period of 40 months. In this study, we compared the genomic landscape of the SM-resistant cell line HaCaT/SM to its sensitive parental line HaCaT in order to gain insights into genetic changes associated with continuous alkylation and oxidative stress. We established chromosome numbers by cytogenetics, analyzed DNA copy number changes by means of array Comparative Genomic Hybridization (array CGH), employed the genome-wide chromosome conformation capture technique Hi-C to detect chromosomal translocations, and derived mutational signatures by whole-genome sequencing. We observed that chronic SM exposure eliminated the initially prevailing hypotetraploid cell population in favor of a hyperdiploid one, which contrasts with previous observations that link polyploidization to increased tolerance and adaptability toward genotoxic stress. Furthermore, we observed an accumulation of chromosomal translocations, frequently flanked by DNA copy number changes, which indicates a high rate of DNA double-strand breaks and their misrepair. HaCaT/SM-specific single-nucleotide variants showed enrichment of C > A and T > A transversions and a lower rate of deaminated cytosines in the CpG dinucleotide context. Given the frequent use of HaCaT in toxicology, this study provides a valuable data source with respect to the original genotype of HaCaT and the mutational signatures associated with chronic alkylation and oxidative stress.

Identifiants

pubmed: 33498964
pii: ijms22031146
doi: 10.3390/ijms22031146
pmc: PMC7865644
pii:
doi:

Substances chimiques

Alkylating Agents 0
DNA Adducts 0
DNA 9007-49-2
Mustard Gas T8KEC9FH9P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
J Biol Chem. 1997 May 23;272(21):13916-22
pubmed: 9153253
Int J Clin Pharmacol Ther Toxicol. 1989 Sep;27(9):419-35
pubmed: 2681003
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt F):9-562
pubmed: 23189753
Oncogene. 1995 Sep 7;11(5):961-9
pubmed: 7675455
BMC Genomics. 2019 Apr 18;19(Suppl 9):985
pubmed: 30999860
Eur J Cancer. 1971 Dec;7(6):515-24
pubmed: 5143809
J Cell Biol. 1988 Mar;106(3):761-71
pubmed: 2450098
Nature. 1999 Oct 21;401(6755):788-91
pubmed: 10548103
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Acta Oncol. 1994;33(6):591-8
pubmed: 7946433
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
J Am Med Assoc. 1946 Sep 21;132:126-32
pubmed: 20997191
Cell Syst. 2016 Jul;3(1):95-8
pubmed: 27467249
PLoS One. 2012;7(9):e44196
pubmed: 23028501
Front Oncol. 2018 May 30;8:183
pubmed: 29900125
Oncogene. 2006 Jun 22;25(26):3680-8
pubmed: 16682958
Cell. 2012 May 25;149(5):979-93
pubmed: 22608084
Cell Rep. 2013 Jan 31;3(1):246-59
pubmed: 23318258
Cell Syst. 2018 Feb 28;6(2):256-258.e1
pubmed: 29428417
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Cancer Res. 2008 Nov 1;68(21):8643-53
pubmed: 18974103
Chem Res Toxicol. 2015 Sep 21;28(9):1850-60
pubmed: 26285869
Toxicol Lett. 2018 Sep 1;293:16-20
pubmed: 29551593
Proc Natl Acad Sci U S A. 1983 Jan;80(2):487-91
pubmed: 6300848
Integr Cancer Ther. 2004 Dec;3(4):294-300
pubmed: 15523100
Oncogene. 2017 Apr 20;36(16):2215-2227
pubmed: 27869163
Toxicol Lett. 2016 Feb 26;244:49-55
pubmed: 26456177
Bioinformatics. 2009 Jul 15;25(14):1841-2
pubmed: 19468054
Nat Chem Biol. 2013 Jul;9(7):455-61
pubmed: 23685671
Chem Res Toxicol. 1994 Mar-Apr;7(2):199-204
pubmed: 8199309
Immunopharmacol Immunotoxicol. 2018 Aug;40(4):290-296
pubmed: 29676192
Dtsch Med Wochenschr. 1975 Apr 25;100(17):919-23
pubmed: 1122860
Fundam Appl Toxicol. 1985 Dec;5(6 Pt 2):S134-49
pubmed: 2419197
Genome Res. 2014 Dec;24(12):2022-32
pubmed: 25236618
EMBO J. 2010 May 19;29(10):1738-47
pubmed: 20400942
Cell. 1985 Mar;40(3):483-4
pubmed: 2982494
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Anticancer Drugs. 2002 Mar;13(3):211-20
pubmed: 11984064
J Cell Biol. 2015 May 25;209(4):485-91
pubmed: 26008741
Mol Carcinog. 1998 Nov;23(3):144-58
pubmed: 9833775
Nucleic Acids Res. 2013 Jan;41(Database issue):D94-D100
pubmed: 23125372
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
J Invest Dermatol. 1999 Mar;112(3):343-53
pubmed: 10084313
Nucleic Acids Res. 2013 Apr 1;41(6):e67
pubmed: 23303777
Toxicol Lett. 2016 Feb 26;244:44-48
pubmed: 26463895
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell Cycle. 2007 May 2;6(9):1044-8
pubmed: 17457056
Radiat Res. 2007 May;167(5):615-23
pubmed: 17474790
Genes Chromosomes Cancer. 2013 Nov;52(11):1017-29
pubmed: 23929738
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
Cell. 2013 Apr 25;153(3):666-77
pubmed: 23622249
Genome Biol. 2017 Jun 27;18(1):125
pubmed: 28655341
J Biochem Mol Biol. 2003 Jan 31;36(1):12-9
pubmed: 12542970
Drug Chem Toxicol. 2013 Jul;36(3):270-6
pubmed: 22947058
Cell. 2019 May 2;177(4):821-836.e16
pubmed: 30982602
Biostatistics. 2004 Oct;5(4):557-72
pubmed: 15475419
Genome Med. 2018 Apr 25;10(1):33
pubmed: 29695279
Toxicology. 2011 Feb 4;280(1-2):53-60
pubmed: 21115096
J Appl Toxicol. 1996 May-Jun;16(3):245-8
pubmed: 8818865
Carcinogenesis. 1993 May;14(5):833-9
pubmed: 8504475
Curr Top Med Chem. 2019;19(9):691-712
pubmed: 30931858
Bioinformatics. 2019 Aug 15;35(16):2847-2849
pubmed: 30596895
Toxicology. 2005 Oct 30;214(3):167-81
pubmed: 16111798
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Fundam Clin Pharmacol. 2005 Jun;19(3):297-315
pubmed: 15910653
DNA Repair (Amst). 2019 Jan;73:49-54
pubmed: 30448017
Pharmacol Rev. 1996 Jun;48(2):289-326
pubmed: 8804107
BMC Bioinformatics. 2017 Jan 6;18(1):19
pubmed: 28061750
Gan. 1953 Sep;44(2-3):216-8
pubmed: 13128117
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Oncotarget. 2014 Nov 30;5(22):10959-60
pubmed: 25526024
Int J Cancer. 2005 Aug 10;116(1):20-6
pubmed: 15756686
Acta Pathol Jpn. 1986 Apr;36(4):533-42
pubmed: 3014812
Genome Biol. 2015 Sep 28;16:214
pubmed: 26415882
Nat Biotechnol. 2013 Dec;31(12):1119-25
pubmed: 24185095
Chem Res Toxicol. 2018 Apr 16;31(4):211-222
pubmed: 29569912
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Can J Biochem. 1971 Mar;49(3):332-6
pubmed: 5549736
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):708-13
pubmed: 2985004
Mutat Res. 2009 Aug;678(2):76-94
pubmed: 19465146
Nature. 1993 Dec 2;366(6454):398-9
pubmed: 8247139
Chem Biol Interact. 1994 Apr;91(1):39-49
pubmed: 8194124
Bioinformatics. 2016 Apr 15;32(8):1211-3
pubmed: 26668005
PLoS Comput Biol. 2012 May;8(5):e1002529
pubmed: 22693437
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Genes Chromosomes Cancer. 1997 Aug;19(4):201-14
pubmed: 9258654
Chem Biol Interact. 2001 Dec 21;138(3):231-45
pubmed: 11714481
Bioinformatics. 2007 Mar 15;23(6):657-63
pubmed: 17234643
Biochemistry. 1983 Sep 13;22(19):4518-26
pubmed: 6354260
Mol Pharmacol. 1987 Jun;31(6):575-8
pubmed: 3600602
IARC Monogr Eval Carcinog Risks Hum Suppl. 1987;7:1-440
pubmed: 3482203

Auteurs

Reinhard Ullmann (R)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Benjamin Valentin Becker (BV)

Bundeswehr Central Hospital, Department of Radiology and Neuroradiology, Rübenacherstrasse 170, D-56072 Koblenz, Germany.

Simone Rothmiller (S)

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstr. 11, D-80937 Munich, Germany.

Annette Schmidt (A)

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstr. 11, D-80937 Munich, Germany.

Horst Thiermann (H)

Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstr. 11, D-80937 Munich, Germany.

Hanns Leonhard Kaatsch (HL)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Gerrit Schrock (G)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Jessica Müller (J)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Julia Jakobi (J)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Richard Obermair (R)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Matthias Port (M)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Harry Scherthan (H)

Bundeswehr Institute of Radiobiology Affiliated to the University of Ulm, Neuherbergstr. 11, D-80937 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH